COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Changchun High-Tech Industry Group

Life-sciences group whose GeneScience unit develops and commercializes recombinant protein medicines, including growth-hormone products.

TICKER000661.SZ

HEADQUARTERSChangchun, China

STAGEApproved

ACTIVE TRIALS50

Therapeutic areas

EndocrinologyPediatricsReproductive Health

Selected products and programs

recombinant human growth hormonelong-acting growth hormone

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets

Phase 3 · Recruiting · Hyperprolactinemia

Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Phase 3 · Recruiting · Non-small Cell Lung Cancer

To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection

Phase 3 · Not Yet Recruiting · Idiopathic Hypogonadotropic Hypogonadism

Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue

NA · Recruiting · Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line Treatment

Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors

NA · Recruiting · Cachexia

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Phase 2 · Recruiting · Systemic Sclerosis Associated Interstitial Lung Disease

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier: /companies/changchun-high-tech-industry-group/
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record